BEAD20260181 - PROCUREMENT OF PROGESTAGENS OR PROGESTINS - LEVONORGESTREL AND MEDROXYPROGESTERONE

This tender, identified as BEAD20260181, concerns the procurement of progestagens or progestins, specifically Levonorgestrel and Medroxyprogesterone. These are pharmaceutical compounds commonly used in hormonal therapies, including contraception and hormone replacement. The procurement is likely for a public health program or a healthcare institution aiming to ensure a stable supply of these essential medications. The tender document will detail the required quantities, specifications, quality standards, packaging, and delivery timelines for these pharmaceutical products. Potential bidders are expected to be manufacturers or authorized distributors capable of supplying high-quality, regulated pharmaceutical goods. Compliance with relevant national and international pharmaceutical regulations, including Good Manufacturing Practices (GMP), will be a key requirement. The objective is to secure a reliable source of these vital medications to meet patient needs and public health objectives. Further details regarding the submission process, evaluation criteria, and contract duration will be provided in the full tender documentation.

This is a supplies contract in the health and medical services, trade and industry and general supplies sectors. Located in Portugal, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 32.

Published through base_gov_pt, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.